$57.71 0.25 (0.43%)
18:30 EST PRGO Stock Quote Delayed 15 Minutes
Previous Close $57.71
Market Cap 8.44B
PE Ratio -
Volume (Avg. Vol.) 783,100
Day's Range 57.06 - 58.21
52-Week Range 40.68 - 60.98
Dividend & Yield 0.73 (1.26%)
PRGO Stock Predictions, Articles, and Perrigo News
- From InvestorPlace
- From the Web
During busy times it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these stocks to buy
Markets ended lower with retail, oil and materials hurt the most as soft economic data all but guarantees a December rate hike.
Mylan (MYL) has launched a hostile takeover of drugmaker Perrigo (PRGO) and it will be up to investors to decide the winner.
Healthcare stocks finished up 1.5% on Wall Street on Wednesday.
Healthcare stocks rose 2.1% on Wall Street today.
My latest portfolio grader rankings will give you a road map for your next portfolio moves. Here are 53 stock upgrades and downgrades to start
Healthcare stocks declined 0.3% on Wall Street today.
Healthcare stocks finished down 1.5% on Wall Street on Wednesday.
Healthcare stocks advanced 0.7% on Wall Street so far on Thursday.
After its hostile bid for Perrigo (PRGO), technical analysis points to a bearish setup on Mylan (MYL) stock to play a break below $45.
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.6%.
Mylan (MYL), GameStop (GME) and Autodesk (ADSK) just couldn't get anything going during Friday's lethargic session.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks rose 0.9% on Wall Street so far on Wednesday.
Healthcare stocks declined 0.1% on Wall Street on Thursday.
Healthcare stocks remained flat on Monday morning on Wall Street.
Teva and Allergan benefit the most from the $40 billion deal, but prospects remain bright for Mylan, Perrigo and, indeed, the wider sector.
Healthcare stocks finished up broadly on Wall Street on Tuesday, with the sector seeing an overall increase of 0.4%.
From Simply Wall St
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-prgo/perrigo/news/read-this-before-buying-perrigo-company-plc-nyseprgo-shares/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader